129.84

1.03% 1.32

Transmedics Group Inc (TMDX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TMDX? Forum Prognose

Schlusskurs vom Vortag:

$128.52

Offen:

$127.5

24-Stunden-Volumen:

434.88K

Relative Volume:

0.59

Marktkapitalisierung:

$4.44B

Einnahmen:

$531.29M

Nettoeinkommen (Verlust:

$71.66M

KGV:

67.14

EPS:

1.9338

Netto-Cashflow:

$17.35M

1W Leistung:

-3.86%

1M Leistung:

-9.02%

6M Leistung:

-1.67%

1J Leistung:

+82.31%

1-Tages-Spanne:

$127.50

$132.22

1-Wochen-Bereich:

$127.50

$140.72

52-Wochen-Spanne:

$62.07

$156.00

Transmedics Group Inc Stock (TMDX) Company Profile

Firmenname

Transmedics Group Inc

Sektor

Healthcare (1111)

Branche

Medical Devices (139)

Telefon

(978) 552-0900

Adresse

200 MINUTEMAN ROAD, ANDOVER, MA

Mitarbeiter

728

Twitter

@transmedics

Nächster Verdiensttermin

2024-10-28

Neueste SEC-Einreichungen

TMDX's Discussions on Twitter

Compare TMDX vs ABT, SYK, MDT, BSX, EW

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TMDX Transmedics Group Inc	129.84	4.39B	531.29M	71.66M	17.35M	1.9338
ABT Abbott Laboratories	112.68	193.83B	44.33B	6.48B	6.92B	3.7033
SYK Stryker Corp	366.05	140.01B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	99.49	129.33B	34.76B	4.79B	5.21B	3.7017
BSX Boston Scientific Corp	74.73	109.92B	20.08B	2.89B	3.82B	1.9391
EW Edwards Lifesciences Corp	75.87	44.36B	6.07B	1.06B	799.60M	1.8527

Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-10-23	Hochstufung	Needham	Hold → Buy
2025-10-13	Eingeleitet	Jefferies	Buy
2025-09-16	Eingeleitet	Evercore ISI	Outperform
2025-09-04	Eingeleitet	Stifel	Hold
2024-12-17	Herabstufung	JP Morgan	Overweight → Neutral
2024-11-22	Herabstufung	Needham	Buy → Hold
2024-10-29	Bestätigt	Needham	Buy
2024-10-29	Bestätigt	Oppenheimer	Outperform
2024-09-24	Eingeleitet	Robert W. Baird	Outperform
2024-08-21	Eingeleitet	Needham	Buy
2024-06-06	Eingeleitet	Cantor Fitzgerald	Overweight
2024-06-04	Eingeleitet	Stephens	Overweight
2024-03-28	Eingeleitet	Piper Sandler	Overweight
2023-07-19	Eingeleitet	Robert W. Baird	Outperform
2022-08-02	Hochstufung	JP Morgan	Neutral → Overweight
2020-10-08	Herabstufung	JP Morgan	Overweight → Neutral
2020-04-07	Eingeleitet	Oppenheimer	Outperform
2019-05-28	Eingeleitet	Canaccord Genuity	Buy
2019-05-28	Eingeleitet	Cowen	Outperform
2019-05-28	Eingeleitet	JP Morgan	Overweight
2019-05-28	Eingeleitet	Morgan Stanley	Equal-Weight

Alle ansehen

Transmedics Group Inc Aktie (TMDX) Neueste Nachrichten

02:07 AM

Wall Street Zen Upgrades TransMedics Group (NASDAQ:TMDX) to Buy - MarketBeat

02:07 AM

Feb 13, 2026

Will TransMedics Group Inc. outperform the market in YEARBuy Signal & Weekly High Potential Stock Alerts - mfd.ru

Feb 13, 2026

Feb 12, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Investors to Inquire about Securities Investigation - ACCESS Newswire

Feb 12, 2026

Is Now An Opportune Moment To Examine TransMedics Group, Inc. (NASDAQ:TMDX)? - Yahoo Finance

Feb 12, 2026

How Do Investors Really Feel About TransMedics Group Inc? - Benzinga

Feb 12, 2026

Big Money Moves: What makes TransMedics Group Inc stock attractive todayMarket Rally & Fast Exit and Entry Trade Guides - baoquankhu1.vn

Feb 12, 2026

Feb 11, 2026

What Is TransMedics Group, Inc.'s (NASDAQ:TMDX) Share Price Doing? - 富途牛牛

Feb 11, 2026

TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - Sahm

Feb 11, 2026

Feb 10, 2026

TransMedics receives full FDA approval for heart transplant trial By Investing.com - Investing.com Nigeria

Feb 10, 2026

Feb 09, 2026

TransMedics (TMDX) Secures FDA Approval for Advanced Heart Device Trial - GuruFocus

Feb 09, 2026

TransMedics receives full and unconditional FDA IDE approval for next-generation OCS Heart Enhance trial - marketscreener.com

Feb 09, 2026

TransMedics receives full FDA approval for heart transplant trial - Investing.com

Feb 09, 2026

TransMedics' 650+ patient heart transplant trial gets full FDA go-ahead - Stock Titan

Feb 09, 2026

New York State Common Retirement Fund Sells 134,406 Shares of TransMedics Group, Inc. $TMDX - MarketBeat

Feb 09, 2026

Feb 08, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Reach Out - ACCESS Newswire

Feb 08, 2026

Seaport Research to Host Virtual Meeting Focusing on TMDX - GuruFocus

Feb 08, 2026

Feb 07, 2026

Renaissance Group LLC Acquires Shares of 76,078 TransMedics Group, Inc. $TMDX - MarketBeat

Feb 07, 2026

Principal Financial Group Inc. Purchases 53,995 Shares of TransMedics Group, Inc. $TMDX - MarketBeat

Feb 07, 2026

TD Cowen Sticks to Its Buy Rating for TransMedics Group (TMDX) - The Globe and Mail

Feb 07, 2026

Feb 06, 2026

TransMedics Group Names New Commercial Leader - The Globe and Mail

Feb 06, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Connect - ACCESS Newswire

Feb 06, 2026

Feb 04, 2026

Commit To Buy TransMedics Group At $80, Earn 16.2% Using Options - Nasdaq

Feb 04, 2026

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), UnitedHealth (UNH) and Johnson & Johnson (JNJ) - The Globe and Mail

Feb 04, 2026

TransMedics Group Inc (NASDAQ:TMDX): A GARP Stock with Strong Growth at a Fair Price - ChartMill

Feb 04, 2026

Up 95% In Last 12 Months, Can TransMedics Stock Keep Climbing In 2026? - TIKR.com

Feb 04, 2026

Feb 03, 2026